Artwork

Content provided by Eric Glazer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Glazer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How Psychedelics Can Bend the Mental Health Cost Curve

37:20
 
Share
 

Manage episode 367329257 series 2556560
Content provided by Eric Glazer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Glazer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelic Researcher and Psychologist Alex Belser, PhD, joins Eric to discuss the efficacy and safety of psychedelics, how they are being applied in practice and the potential pharmacoeconomic and business impact this category of medications can have on patients with severe mental illness.

Alex shares information on the latest research and developments in psychedelics and dispels some of the myths around usage. He also discusses how psychedelics may be more cost-effective than conventional drug treatments for mental health issues and how the medications could change mental health care as we know it.

About Alex

Dr. Alex Belser is a licensed psychologist and researcher focused on psilocybin, MDMA, and DMT therapies. At Yale, Dr. Belser is investigating a psychedelic treatment for OCD. He is the Chief Clinical Officer of Cybin, where he is the co-creator of a new model of psychedelic-assisted psychotherapy called EMBARK.

  continue reading

99 episodes

Artwork
iconShare
 
Manage episode 367329257 series 2556560
Content provided by Eric Glazer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Glazer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelic Researcher and Psychologist Alex Belser, PhD, joins Eric to discuss the efficacy and safety of psychedelics, how they are being applied in practice and the potential pharmacoeconomic and business impact this category of medications can have on patients with severe mental illness.

Alex shares information on the latest research and developments in psychedelics and dispels some of the myths around usage. He also discusses how psychedelics may be more cost-effective than conventional drug treatments for mental health issues and how the medications could change mental health care as we know it.

About Alex

Dr. Alex Belser is a licensed psychologist and researcher focused on psilocybin, MDMA, and DMT therapies. At Yale, Dr. Belser is investigating a psychedelic treatment for OCD. He is the Chief Clinical Officer of Cybin, where he is the co-creator of a new model of psychedelic-assisted psychotherapy called EMBARK.

  continue reading

99 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide